skip to Main Content
Provider Portal
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CIRCULOGENE Announces Appointment of Bob Gasparini to Board of Directors

BIRMINGHAM, Ala. and Pensacola, Fla. (December 8, 2022) – CIRCULOGENE is an innovative liquid biopsy company transforming precision…

CIRCULOGENE shares results of remarkable rectal cancer study

FOR IMMEDIATE RELEASE CIRCULOGENE shares results of remarkable rectal cancer study Identifying mismatch repair-deficient (MMRd)…

CIRCULOGENE Announces Lab Expansion in Florida

FOR IMMEDIATE RELEASE CIRCULOGENE Announces Lab Expansion in Florida Liquid Biopsy Company Laboratory Operations Are…

CIRCULOGENE Announces Issuance of U.S. Patent for Method of Preparing Cell-Free Nucleic Acid Molecules by In Situ Amplification

Issued patent recognizes CIRCULOGENE’s novel method of enriching cfDNA without DNA isolation, extraction or purification,…

Biological Fragmentation of Circulating Cell-free DNA Alters Genetic Representation

 Current Trends in Clinical & Medical Sciences  Chen Hsiung Yeh* Circulogene Theranostics, Birmingham, USA Received Date: January…

CIRCULOGENE Molecular Diagnostics Laboratory Receives College of American Pathologists (CAP) Accreditation

 BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, announced today that its…

Back To Top